Trends in the incidence of the Epstein-Barr virus-associated malignancies extranodal NK/T-cell lymphoma and nasopharyngeal carcinoma in Taiwan

被引:0
|
作者
Yeh, Shyh-An [1 ,2 ,3 ,4 ]
Chiu, Liang-Chun [5 ]
Lin, Hsin-Chieh [6 ,7 ]
Li, Hung-Ju [8 ]
Lin, Sheng-Fung [8 ]
Su, Yu-Chieh [8 ,9 ,10 ]
机构
[1] Natl Kaohsiung Univ Sci & Technol, Med Phys & Informat Lab Elect Engn, Kaohsiung, Taiwan
[2] Natl Kaohsiung Univ Sci & Technol, Dept Elect Engn, Kaohsiung, Taiwan
[3] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan
[4] I Shou Univ, E DA Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[5] I Shou Univ, E Da Dachang Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[6] I Shou Univ, E Da Canc Hosp, Dept Chinese Med, Kaohsiung, Taiwan
[7] I Shou Univ, Sch Chinese Med Post Baccalaureate, Coll Med, Kaohsiung, Taiwan
[8] I Shou Univ, E Da Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan
[9] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan
[10] I Shou Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan
来源
PLOS ONE | 2024年 / 19卷 / 12期
关键词
EPIDEMIOLOGY; NASAL; JAPAN; RISK;
D O I
10.1371/journal.pone.0315380
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nasopharyngeal carcinoma (NPC) and extranodal NK/T-cell lymphoma (ENKTL) are associated with the Epstein-Barr virus (EBV). The current study aimed to evaluate the trends in the incidence of ENKTL and NPC in Taiwan within the last 15-30 years. To assess the incidence of ENKTL from 2008 to 2021 and NPC from 1995 to 2021, an epidemiological study was performed using population-based registry data from the Taiwan Cancer Registry. The secular trends in the annual incidence rates were expressed as average annual percent change (AAPC). During the study period, 872 new ENKTL diagnoses and 39412 new NPC diagnoses were reported. The annual age-adjusted incidence rates of ENKTL and NPC decreased significantly, with an AAPC of -2.47 (p = 0.014) and -1.16 (p < 0.001), respectively. The incidence rates of NPC from 1995 to 2021 in the 20-44-, 45-64-, and >= 65-year-old age groups decreased from 5.23 to 4.42 per 100,000 person-years (AAPC = -0.45, p = 0.011), from 15.28 to 11.36 per 100,000 person-years (AAPC = -1.21, p < 0.001), and from 10.48 to 7.24 per 100,000 person-years (AAPC = -1.91, p < 0.001), respectively. The age-specific incidence rates of ENKTL in the 45-64-year-old age group significantly decreased from 0.46 to 0.32 per 100,000 person-years during 2008-2021 (AAPC = -3.37, p = 0.008). The incidence of ENKTL between 2008 and 2021 in the 20-44- and >= 65-year-old age groups also decreased from 0.16 to 0.11 per 100,000 person-years and from 0.87 to 0.79 per 100,000 person-years, respectively. Interestingly, the EBV seroprevalence in Taiwan remained stable from 1984 to 2007. Nonetheless, there was a downward trend in the EBV seroprevalence in early childhood, with a decrease of approximately 20% in children aged 4 years and nearly 50% in children aged <2 years. Based on these findings, the downward trend in the incidence of NPC/ENKTL could be affected by the decline in early EBV infection rates. Considering that the EBV seroprevalence remained stable but the incidence rate of early EBV infection decreased during the same period, delayed EBV infection or factors other than EBV might play an important role in the downward trend in the incidence of NPC/ENKTL in Taiwan. Nevertheless, further investigations should be performed to assess these results.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] CYTOGENETIC CHARACTERIZATION OF EPSTEIN-BARR VIRUS-ASSOCIATED T-CELL MALIGNANCIES
    TIEN, HF
    SU, IJ
    CHUANG, SM
    LEE, FY
    LIU, MC
    TSAI, TF
    LIN, KH
    CHEN, RL
    CANCER GENETICS AND CYTOGENETICS, 1993, 69 (01) : 25 - 30
  • [2] CLINICOPATHOLOGICAL SPECTRUM OF EPSTEIN-BARR VIRUS-ASSOCIATED T-CELL MALIGNANCIES
    SU, IJ
    HSIEH, HC
    LEUKEMIA & LYMPHOMA, 1992, 7 (1-2) : 47 - 53
  • [3] Ocular involvement in Epstein-Barr virus-associated T-cell lymphoma
    Cochereau, I
    Hannouche, D
    Geoffray, C
    Toublanc, M
    Thanh, HX
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (03) : 322 - 324
  • [4] Treatment of Epstein-Barr virus-associated peripheral T-cell lymphoma
    Imashuku, S
    Teramura, T
    Konishi, K
    Kikuchi, A
    Tamura, S
    Maeda, Y
    Kuroda, H
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) : 1038 - 1040
  • [5] Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma and NK/T-cell lymphoma
    Jasso Olivares, Julio Cesar
    Dominguez-Cherit, Judith
    Garcia Hidalgo, Linda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB145 - AB145
  • [6] Epstein-Barr virus-associated extranodal NK/T-cell lymphoma following mosquito bites in an elderly patient without prior hypersensitivity
    Tomita, N
    Kanamori, H
    Fujimaki, K
    Fujisawa, S
    Ishigatsubo, Y
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 2153 - 2155
  • [7] Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma
    Morrison, JA
    Gulley, ML
    Pathmanathan, R
    Raab-Traub, N
    CANCER RESEARCH, 2004, 64 (15) : 5251 - 5260
  • [8] EPSTEIN-BARR VIRUS-ASSOCIATED ANTIGENS IN NASOPHARYNGEAL CARCINOMA
    COATES, HL
    PEARSON, GR
    NEEL, HB
    WEILAND, LH
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1978, 104 (08) : 427 - 430
  • [9] Epstein-Barr virus-associated peripheral T-cell lymphoma showing folliculotropism
    Choi, HJ
    Han, SS
    Kim, KJ
    Chang, SE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P139 - P139
  • [10] EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    RICHTSMEIER, WJ
    WITTELS, EG
    MAZUR, EM
    CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (02): : 105 - 136